Moreover, lower frequencies of PB-circulating CD127+ lymphocytes (< 5%) were associated with beneficial survival in rectal and breast cancer patients, but not in patients diagnosed with liver, gastric, esophageal, ovarian, or colon cancer (106). This evidence concerns the gene IL7R and breast carcinoma.